Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

6(60.0%)

Phase 3

2(20.0%)

Phase 4

2(20.0%)

10Total

N/A(6)

Phase 3(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT07225153Not ApplicableRecruiting

Goat Milk-Derived Formula vs. Undiluted Goat Milk in Infants Unable to Exclusively Breastfeed: Growth and Biomarker Analysis

Role: collaborator

NCT01620684Phase 4Unknown

Cortisol and Nutritional Sympathetic Responsiveness

Role: lead

NCT01771042Not ApplicableUnknown

The Effects of Weight Loss on Neuroadrenergic Function

Role: lead

NCT00408850Phase 3Unknown

Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity

Role: lead

NCT00395148Not ApplicableCompleted

Improving Metabolism With HDL Cholesterol

Role: collaborator

NCT00168519Not ApplicableCompleted

Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes

Role: lead

NCT00666861Terminated

Type 2 Diabetes and Exercise - A Pilot Study

Role: collaborator

NCT00168467Phase 4Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Role: lead

NCT00168493Not ApplicableUnknown

The Neurobiology of Depressive Illness

Role: lead

NCT00485368Phase 3Completed

Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

Role: collaborator

NCT00168506Not ApplicableUnknown

Panic Disorder and Cardiac Risk

Role: lead

All 11 trials loaded